Medicine and Dentistry
Acute Kidney Injury
79%
Albumin
18%
Aldosterone
18%
Analysis
29%
Angiography
12%
Anti-Inflammatory Drug
11%
Association
11%
Atlas
14%
Biological Marker
18%
Cardiovascular System
25%
Cells
26%
Chronic Kidney Disease
90%
Combination Therapy
12%
Comprehension
11%
Creatinine
21%
Development
15%
Diagnosis
11%
Diseases
23%
Diuretic Agent
10%
Empagliflozin
18%
Fatigue
16%
Glomerular Filtration Rate
18%
Hazard Ratio
10%
Heart Failure
12%
Heart Right Ventricle Failure
12%
Hemodialysis
22%
Histopathology
18%
Hypertension
15%
Idiopathic Pulmonary Fibrosis
16%
Incidence
11%
Inpatient
41%
Intervention Trial
13%
Kidney
41%
Kidney
18%
Kidney Function
13%
Mortality
16%
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
12%
Nephrology
11%
Nephropathy
38%
Pathophysiology
12%
Patient
100%
Personalized Medicine
29%
Plasma
14%
Prevalence
11%
Protein
13%
Pulmonary Hypertension
27%
Renal Biopsy
23%
Systolic Blood Pressure
15%
Therapeutic Procedure
16%
Urinary System
22%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
42%
Acute Kidney Failure
9%
Albumin
14%
Aldosterone Antagonist
7%
Atrasentan
9%
Biological Marker
18%
Blindness
9%
Branched Chain Amino Acid
7%
Cadherin
6%
Cardiogenic Shock
7%
Chronic Kidney Failure
29%
Chronic Kidney Failure
8%
Dehydration
9%
Dialysis
27%
Diuretic Agent
9%
Diuretics
10%
End Stage Renal Disease
14%
Endotoxemia
12%
Ergocalciferol
9%
Erythropoietin
17%
Fatigue
16%
Finerenone
9%
Ghrelin
8%
Heart Failure
8%
Hemodialysis
29%
Hyperkalemia
10%
Hypertension
6%
Injury
9%
Interleukin 6
7%
Ischemia
6%
Kidney Disease
9%
Kidney Fibrosis
6%
Lipopolysaccharide
7%
Morbid Obesity
9%
Mortality
10%
Mouse
8%
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
9%
Neutrophil Gelatinase Associated Lipocalin
6%
Non Insulin Dependent Diabetes Mellitus
9%
Pathophysiology
8%
Pentoxifylline
9%
Peritoneal Dialysis Fluid
9%
Peritonitis
13%
Phloretin
9%
Pigment Epithelium Derived Factor
6%
Protein
19%
Pulmonary Hypertension
9%
Reactive Oxygen Metabolite
6%
Resistant Hypertension
9%
Shock
9%